Pfizer moves forward with once-daily weight-loss pill
Jul 12, 2024
Washington [US], July 12: Pfizer (PFE.N), opens new tab plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice- daily version of the drug late last year.
Read More ..